1. Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6.
- Author
-
Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD, and Na S
- Subjects
- Animals, Antigen Presentation, Antigens, CD metabolism, Apoptosis, B-Lymphocytes cytology, B7-2 Antigen, Cell Division, Cell Survival, Cells, Cultured, Down-Regulation, Flow Cytometry, Gene Deletion, Immunohistochemistry, Membrane Glycoproteins metabolism, Mice, Mice, Knockout, Mitogens immunology, Proto-Oncogene Proteins c-bcl-2 metabolism, Proto-Oncogene Proteins c-rel metabolism, Receptors, Tumor Necrosis Factor deficiency, Receptors, Tumor Necrosis Factor genetics, T-Lymphocytes immunology, Up-Regulation, bcl-X Protein, B-Lymphocytes immunology, B-Lymphocytes metabolism, Lymphocyte Activation, Receptors, Tumor Necrosis Factor metabolism
- Abstract
Targeted disruption of death receptor (DR)6 results in enhanced CD4(+) T cell expansion and T helper cell type 2 differentiation after stimulation. Similar to T cells, DR6 is expressed on resting B cells but is down-regulated upon activation. We examined DR6(-/-) B cell responses both in vitro and in vivo. In vitro, DR6(-/-) B cells undergo increased proliferation in response to anti-immunoglobulin M, anti-CD40, and lipopolysaccharide. This hyperproliferative response was due, at least in part, to both increased cell division and reduced cell apoptosis when compared with wild-type B cells. Consistent with these observations, increased nuclear levels and activity of nuclear factor kappaB transcription factor, c-Rel, and elevated Bcl-x(l) expression were observed in DR6(-/-) B cells upon stimulation. In addition, DR6(-/-) B cells exhibited higher surface levels of CD86 upon activation and were more effective as antigen-presenting cells in an allogeneic T cell proliferation response. DR6(-/-) mice exhibited enhanced germinal center formation and increased titers of immunoglobulins to T-dependent as well as T-independent type I and II antigens. This is the first demonstration of a regulatory role of DR6 in the activation and function of B cells.
- Published
- 2003
- Full Text
- View/download PDF